Orchestra BioMed Director David Pacitti Receives Equity Awards

This Form 4 filing discloses equity transactions by David Pacitti, a director of Orchestra BioMed Holdings, Inc. On June 23, 2026, Pacitti received 17,327 restricted stock units (RSUs) that vest after one year of continuous service. The same day, he was granted 21,277 stock options with an exercise price of $4.04 per share, also vesting after one year. On June 24, 2026, 3,784 shares were withheld to satisfy tax obligations related to vesting RSUs, with no market sale of shares. Following these transactions, Pacitti holds 58,511 shares of common stock and 21,277 stock options. The filing represents standard director compensation through equity awards with standard vesting conditions and tax withholding procedures.